Proteins with a short half-life are potential sites of pancreatic ss cell dysfunction under pathophysiological conditions. In this study, mouse islets were used to establish which step in the regulation of insulin secretion is most sensitive to inhibition of protein synthesis by 10 microM cycloheximide (CHX). Although islet protein synthesis was inhibited approximately 95% after 1 h, the inhibition of insulin secretion was delayed and progressive. After long (18-20 h) CHXtreatment, the strong (80%) inhibition of glucose-, tolbutamide-, and K(+)-induced insulin secretion was not due to lower insulin stores, to any marked impairment of glucose metabolism or to altered function of K(+)-ATP channels (total K(+)-ATP currents were however decreased). It was partly caused by a decreased Ca(2+) influx (whole-cell Ca(2+) current) resulting in a smaller rise in cytosolic Ca(2+) ([Ca(2+)](i)). The situation was very different after short (2-5 h) CHX-treatment. Insulin secretion was 50-60% inhi... 
2ϩ current) resulting in a smaller rise in cytosolic Ca 2ϩ ([Ca 2ϩ ] i ). The situation was very different after short (2-5 h) CHX-treatment. Insulin secretion was 50 -60% inhibited although islet glucose metabolism was unaffected and stimulus-induced [Ca 2ϩ ] i rise was not (2 h) or only marginally (5 h) decreased. The efficiency of Ca 2ϩ on secretion was thus impaired. The inhibition of insulin secretion by 15 h of CHX treatment was more slowly reversible (Ͼ4 h) than that of protein synthesis. This reversibility of secretion was largely attributable to recovery of a normal Ca 2ϩ efficiency. In conclusion, inhibition of protein synthesis in islets inhibits insulin secretion in two stages: a rapid decrease in the efficiency of Ca 2ϩ on exocytosis, followed by a decrease in the Ca 2ϩ signal mediated by a slower loss of functional Ca 2ϩ channels. Glucose metabolism and the regulation of K ϩ -ATP channels are more resistant. Proteins with a short half-life appear to be important to ensure optimal Ca 2ϩ effects on exocytosis, and are the potential Achille's heel of stimulus-secretion coupling. (Endocrinology 142: 299 -307, 2001) N ORMAL glucose homeostasis critically depends on the precise control of insulin secretion. This control involves two major pathways that both require metabolism of the sugar by ␤ cells (1) . The first one serves to produce a triggering signal through the following sequence of events: the increase in the ATP/ADP ratio resulting from glucose metabolism closes ATP-sensitive K ϩ channels (K ϩ -ATP channels) in the plasma membrane; the ensuing membrane depolarization opens voltage-dependent Ca 2ϩ channels, allowing Ca 2ϩ influx and rise of free cytosolic Ca 2ϩ ([Ca 2ϩ ] i ) that eventually triggers exocytosis (2) (3) (4) (5) (6) . The second pathway serves to produce as yet incompletely identified amplifying signals that increase the efficiency of Ca 2ϩ on exocytosis (1, (7) (8) (9) .
This elaborated stimulus-secretion coupling implicates a large number of proteins. Many of these proteins are identified and mutations of the gene coding for some of them, e.g.
glucokinase (10 -12) or the sulfonylurea receptor of the K ϩ -ATP channel (13) (14) (15) profoundly perturb ␤ cell function. In contrast, virtually nothing is known about the stability of islet proteins. This is, however, a critical issue because changes in the synthesis or degradation rates of proteins with a short half-life might contribute to the ability or failure of ␤ cells to adapt to various pathophysiological conditions. Thus, distinct cell proteins may have vastly different halflives, from minutes to days. Proteins with a long half-life usually are structural components or perform housekeeping functions, whereas proteins with a short half-life play more specialized, often regulatory, roles.
In the present study, we examined the consequences of a blockade of islet protein synthesis on the regulation of insulin secretion. A similar approach was already used 30 yr ago. Several groups showed that high concentrations of cycloheximide (CHX) and puromycin, two inhibitors of translation, caused a delayed (ϳ60 min) inhibition of glucose-induced insulin secretion from the perfused rat pancreas (16 -18) and isolated rat islets (19) . The initial interpretation that insulin biosynthesis was required for sustained secretion (second phase) was rapidly refuted (20, 21) , but no explanation for the inhibition of insulin secretion by protein synthesis inhibition was ever provided. Assuming that those steps of stimulus-secretion coupling involving the proteins with the smallest pool size and shortest half-life would be first affected, we evaluated the impact of different durations of protein synthesis inhibition on the major events regulating insulin secretion. Remarkably, glucose metabolism and the generation of the triggering signal were only slightly and slowly affected whereas the efficiency of Ca 2ϩ on the secretory process was rapidly impaired.
Materials and Methods

Preparation and solutions
Islets were aseptically isolated by collagenase digestion of the pancreas of fed female NMRI mice followed by hand selection (22) . Except for electrophysiological experiments (see below), the islets were then cultured (generally for 18 h) in 2.5 ml RPMI 1640 medium (Life Technologies, Inc., Paisley, UK) containing 10 mm glucose, 10% heat-inactivated FCS, 2 mm glutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin. The control medium used for islet isolation was a bicarbonate-buffered solution containing (in mm): NaCl 120, KCl 4.8, CaCl 2 2.5, MgCl 2 1.2 and NaHCO 3 24. It was gassed with O 2 /CO 2 (94/6) to maintain a pH of 7.4, and contained 1 mg/ml BSA. The same medium was used for most experiments. When the concentration of KCl was increased to 30 mm, that of NaCl was decreased accordingly. All experiments, except patch-clamp recordings, were carried out at 37 C.
Cycloheximide treatment
CHX was added to the culture medium or the experimental solutions from a 5 mm stock solution prepared daily in sterile water. The treatment with CHX was applied for different periods of time which, for practical reasons (batching of the islets, transfer from culture to preincubation medium) slightly varied: 2 h (120 -135 min), 5 h (4.5-5 h) and 20 h (19 -20 h). Except when indicated otherwise, CHX was not present during the acute tests of islet functioning but was withdrawn just before the start of these tests.
Measurements of insulin secretion and islet insulin content
Insulin secretion during the culture period was measured in aliquots of medium taken after 18 h. When the reversibility of the effects of CHX was studied, the culture medium was changed after 12 h and aliquots of the fresh medium were taken every 3 h. At the end of the culture, the islets were recovered from the Petri dishes, and their insulin content was determined after extraction in acid-ethanol (23) . Insulin was measured by a double-antibody RIA (24) with rat insulin as the standard.
Insulin secretion was also measured in acute experiments using islets cultured with or without CHX. At the end of the culture, the islets were first washed and preincubated in control medium containing CHX or not as appropriate. Batches of 20 islets were then placed in small chambers of a perifusion system (25) . Effluent samples were collected every 2 or 6 min for insulin measurement. In one series of experiments batches of 3 islets were incubated for 1 h in 1 ml medium containing 15 mm glucose with or without 0.5 mm dibutyryl cAMP or 25 nm phorbol myristic acid (PMA) (Sigma, St Louis, MO). At the end of the incubation, a portion of medium was taken for insulin measurement.
Measurements of total protein synthesis
The islets were cultured for 1-18 h in 1.25-2.5 ml RPMI medium supplemented with l- [3,5- 3 H] tyrosine (20 -40 Ci/ml depending on the duration of the experiment), and with or without CHX. At the end of the culture period with the tracer, the medium was removed and the islets were collected and washed 4 times with control medium containing 1 mm nonradioactive tyrosine. They were then distributed in batches of 15 in polyethylene conical tubes, to which 500 l ice-cold trichloracetic acid (10%) was added to precipitate proteins. The tubes were centrifuged, the supernatant was discarded and the pellet was rinsed again with trichloracetic acid (3 times). The pellet was eventually solubilized in 200 l 0.1 m NaOH, and its radioactive content measured by liquid scintillation spectrometry, using Flow-Safe F (Lumac, Groningen, The Netherlands) as scintillator and counting at an efficiency of approximately 60%. The results (cpm/islet) obtained in test groups were expressed as a percentage of those in control islets treated in the same way within the same experiment.
Measurements of glucose oxidation
After culture and preincubation with or without CHX, batches of 10 islets were incubated for 2 h in 50 l control medium supplemented with 1 Ci [U-
14 C] glucose. Oxidation of glucose was calculated from the production of [ 14 C]CO 2 . Technical aspects of the method have been described previously (26) . In these experiments CHX was still present during the incubation.
Measurements of [Ca 2ϩ ] i and NAD(P)H After culture, the islets to be used for [Ca 2ϩ ] i measurements were loaded with fura-PE3 during 2 h of preincubation in the presence of 2 m fura-PE3 acetoxymethylester. The islets to be used for NAD(P)H measurements were preincubated without dye. The medium contained CHX (test islets) or not (control islets). After preincubation, the islets were transferred into the perifusion chamber of a microspectrofluorimeter system that has previously been described in detail (27, 28) . NAD(P)H measurements were obtained from one test and one CHXtreated islet side by side.
Measurements of 86 Rb ϩ efflux
After culture, the islets were loaded with 86 Rb ϩ (used as a tracer for K ϩ ) during 90 min of preincubation in control medium containing 80 Ci 86 RbCl (0.37 mm). The medium contained CHX (test islets) or not (control islets). The islets were then washed with nonradioactive medium and placed in batches of 30 in the same perifusion system as that used to study insulin secretion. The radioactivity lost by the islets was measured in effluent fractions collected at 2 min intervals, and the fractional efflux rate was calculated for each period (25) .
Electrophysiological experiments
After isolation, the islets were dispersed into single cells (29) and cultured on glass coverslips in RPMI 1640 medium as described above. The cells were allowed to attach to the glass during 16 -18 h before addition of CHX to the culture medium for 19 -20 h.
The electrical recordings were made using the amphotericine-perforated whole-cell mode of the patch-clamp technique at 21-23 C (30 -31). Perforation required a few min and the voltage-clamp was considered satisfactory when the series resistance had fallen below 20 m⍀. Membrane currents were measured using an EPC-9 patch-clamp amplifier (Heka Electronics, Lambrecht/Pfalz, Germany) and the software Pulsefit (version 8 -31).
To measure K ϩ -ATP currents, 100 ms depo-and hyperpolarizing pulses of 20 mV were applied alternatively from a holding potential of Ϫ70 mV. The pipette solution was (mm): K 2 SO 4 70, NaCl 10, KCl 10, MgCl 2 3.7, HEPES 5 (adjusted to pH 7.1), and the bath solution was (mm): NaCl 120, KCl 4.8, CaCl 2 2.5, MgCl 2 1.2, NaHCO 3 24, HEPES 5 (adjusted to pH 7.4). To measure Ca 2ϩ currents, the holding potential was Ϫ80 mV, and 100 ms depolarizing pulses were applied to various potentials to 
Presentation of results
Results are presented as means Ϯ sem. The statistical significance of differences between means was assessed by ANOVA followed by a Newman-Keuls test.
Results
Concentration-dependence, onset and reversibility of cycloheximide effects
Addition of CHX to the culture medium for 18 h inhibited insulin secretion and islet protein synthesis in a parallel, concentration-dependent manner with, however, a slightly stronger effect on synthesis than secretion (Fig. 1a) . At the end of the culture period, the insulin content of control islets (cultured without CHX) averaged 100 Ϯ 6 ng, which was 47% less than that of fresh, noncultured islets (P Ͻ 0.001), but the sum of insulin content and secretion (233 Ϯ 6 ng) was 23% larger (P Ͻ 0.05) (Fig. 1b) . Insulin synthesis has thus partially compensated for insulin secretion. This was not the case after culture with CHX: the insulin content was slightly lower than that of fresh islets (P Ͻ 0.01), but the sum of insulin content and secretion was not different. Importantly, the insulin content of islets cultured with CHX was higher (P Ͻ 0.05 or less) than that of control islets (Fig. 1b) . This rules out the trivial possibility that the defects of insulin secretion caused by CHX are simply due to insufficient insulin stores. Because maximum effects were obtained with 10 m CHX, this concentration was used in all subsequent experiments.
To test the reversibility of CHX effects, islets were cultured with or without 10 m CHX for 12 h. This inhibited insulin secretion by 80% (Fig. 2a) . The islets were then transferred to fresh culture medium. When CHX remained present, both insulin secretion and protein synthesis were strongly depressed as compared with controls. When CHX was withdrawn, a significant synthesis of proteins was noted after 3 h (Fig. 2b) , whereas insulin secretion did not significantly increase before 6 h (Fig. 2a) .
Islet protein synthesis was inhibited by 93 and 94% after 1 and 4 h of treatment with 10 m CHX. The effect of the drug was thus rapid and complete at the concentration used. In contrast, no inhibition of glucose-induced insulin secretion occurred before about 1 h (Fig. 3) . There was thus a clear temporal sequence in the effects of CHX: upon addition of the drug, the inhibition of insulin secretion was delayed and progressive compared with that of protein synthesis; upon withdrawal of CHX, recovery of insulin secretion followed resumption of protein synthesis.
Insulin secretion by islets pretreated with cycloheximide
Islets from the same preparation were treated with 10 m CHX for 2, 5, or 20 h, and their ability to secrete insulin in response to various stimuli was then tested in a perifusion system. In control islets, 15 mm glucose induced biphasic insulin secretion, and subsequent addition of 100 m tolbutamide strongly potentiated the response (Fig. 4a) . By opening K ϩ -ATP channels and preventing ␤ cell depolarization (32, 33) , diazoxide abolished glucose-induced insulin secretion, but a rise in extracellular K ϩ to 30 mm triggered a large monophasic response (Fig. 4b) (7) . After 20 h of CHX treatment, the stimulatory effects of glucose, tolbutamide, and high K ϩ were markedly (60 -80%) impaired. The inhibition increased with the duration of CHX pretreatment, but the major impairment (P Ͻ 0.001) occurred early, during the first two hours, regardless of the stimulus (Fig. 4, c-e) .
In another series of experiments the islets were treated with 10 m CHX for 2 h before being incubated in batches of 3 in 1 ml of medium containing 15 mm glucose. Insulin secretion averaged 3.8 Ϯ 0.15 and 1.7 Ϯ 0.16 ng/islet/h in control and CHX-treated islets, respectively (n ϭ 16, P Ͻ 0.01). In control islets insulin secretion was markedly potentiated by 0.5 mm dibutyryl cAMP (342 Ϯ 18%) or 25 nm PMA (208 Ϯ 8%). Similar potentiations were observed when CHXtreated islets were stimulated with dibutyryl cAMP (348 Ϯ 29%) or PMA (284 Ϯ 16%). The protein kinase A and protein kinase C pathways are thus functional after 2 h of treatment with CHX.
Glucose metabolism by islets pretreated with cycloheximide
The effect of glucose on ␤ cell metabolism was first measured by recording the NAD(P)H fluorescence of the islets (34, 35) . Raising the concentration of glucose from 3 to 15 mm markedly and reversibly increased the signal (Fig. 5a ). The response was not different from that of controls after 5 h of treatment with 10 m CHX, but it was partially impaired (P Ͻ 0.01) after 20 h of treatment. This slight alteration of glucose metabolism was confirmed by measurements of glucose oxidation (Fig. 5b) . In both low and high glucose, CO 2 production from glucose was slightly reduced by 20 h CHX treatment (20 and 16%, respectively, P Ͻ 0.01). The inhibition was not larger when the concentration of CHX was raised to 100 m during the 20 h of treatment (not shown), indicating that the small change in glucose metabolism is secondary to inhibition of protein synthesis (already maximal with 10 m CHX) rather than to a side effect of the drug. the regulation of K ϩ permeability in ␤ cells under basal and stimulating conditions (36) . In control islets perifused with a glucose-free medium, the rate of 86 Rb ϩ efflux was high, reflecting a high permeability of the membrane to K ϩ (Fig. 6 ). Addition of 3 and then 15 mm glucose to the medium (Fig.  6a ) or addition of 25 and then 100 m tolbutamide to the glucose-free medium (Fig. 6b) induced a graded and reversible inhibition of 86 Rb ϩ efflux that is known to reflect closure of K ϩ -ATP channels (4, 36) . Similar changes were produced by glucose and tolbutamide when islets had been pretreated with 10 m CHX for 5 h. After 20 h of treatment, however, the basal rate of 86 Rb ϩ efflux was lower than in controls (P Ͻ 0.01), but glucose and tolbutamide still decreased it to a similar minimum rate as in control islets. The magnitude of the inhibitory effect was thus smaller, but the absolute final rate was not different.
The perforated whole-cell configuration of the patch clamp technique was used to study total K ϩ -ATP currents in ␤ cells. A representative experiment is shown in Fig. 7a . K ϩ -ATP currents were initially small because of the presence of 10 mm glucose in the medium. Lowering ␤ cell ATP with 3 mm azide and direct opening of the channels with diazoxide caused a marked increase in K ϩ -ATP currents, which was reversed by tolbutamide. In 10 mm glucose alone, K ϩ -ATP currents were not significantly different in ␤ cells pretreated with 10 m CHX for 20 h and in controls (Fig. 7b) . However, the increase produced by azide and diazoxide was smaller after CHX (P Ͻ 0.01), which suggests that the total number of functional K ϩ -ATP channels was decreased. The relative inhibitory action of tolbutamide was similar in control and CHX treated ␤ cells, so that a significant difference (P Ͻ 0.01) in total current persisted in the presence of the three drugs.
Ca 2ϩ currents in ␤ cells and [Ca 2ϩ ] i changes in islets pretreated with cycloheximide
Depolarization of ␤ cells to Ϫ40 mV or above elicited typical, partially inactivating, Ca 2ϩ currents (Fig. 7c) , that increased in amplitude up to 0 mV and then decreased at more positive potentials (Fig. 7d) . After pretreatment of the cells with 10 m CHX for 20 h, both peak and sustained currents were inhibited by about 40% (P Ͻ 0.001). The percent block was similar at all voltages between Ϫ30 and ϩ50 mV.
Stimulation of control islets with a rise in the glucose concentration from 3 to 15 mm induced [Ca 2ϩ ] i changes in three phases: an initial small decrease (seen in 20/24 islets) was followed by a large increase and eventually by oscillations. These oscillations, illustrated for a representative islet in the inset, are masked by averaging of the traces (Fig. 8a) (Fig. 8a) . This rise was smaller in islets treated with 10 m CHX for 5 h (P Ͻ 0.05) and 20 h (P Ͻ 0.001), but it was unaltered after 2 h of CHX treatment (Fig. 8, a and d) .
When diazoxide was present in the medium containing 15 mm glucose, [Ca 2ϩ ] i was low and stable, but a large and sustained rise occurred when extracellular K ϩ was increased to 30 mm. This rise was inhibited (P Ͻ 0.001) by pretreatment with 10 m CHX for 20 h (Fig. 8, b and e) . Two hours of treatment had no effect, and the small inhibition by 5 h of treatment was significant (P Ͻ 0.05) only when calculated above baseline.
Links between CHX-induced [Ca 2ϩ ] i and insulin secretion changes
The results presented in Figs. 4 and 8 showed that 2 h of CHX treatment inhibited insulin secretion without significantly affecting [Ca 2ϩ ] i , whereas longer treatment decreased the Ca 2ϩ signal as well. Figure 9 displays the relationship . Two excellent correlations with distinct slopes were found for control and CHX-treated islets. Fitting all data with a single regression line resulted in a much weaker coefficient of correlation (R ϭ 0.79). For each stimulus, the inhibition of insulin secretion by CHX treatment appeared to involve two successive changes: an initial decrease in the efficiency of Ca 2ϩ (after 2 h) followed by a decrease in [Ca 2ϩ ] i . We finally tested whether the reversibility of the inhibition by CHX might also occur in two stages. As shown in Fig. 10 , a and b, 5 h of CHX washing after 15 h pretreatment was followed by a greater reversibility of insulin secretion than [Ca 2ϩ ] i during stimulation with high K ϩ . The values of these new control and test experiments fell close to the regression lines calculated from the first experimental series (Fig. 10c) . The critical observation was that the value for the reversibility group did not move along the lower curve of CHXtreated islets, but jumped to the upper curve of control islets. The recovery of secretion thus mainly involved an increase in Ca 2ϩ efficiency.
Discussion
Our study shows that inhibition of protein synthesis in pancreatic islets inhibits insulin secretion by interfering with distinct steps of stimulus-secretion coupling in a time-dependent manner, compatible with the sequential disappearance of distinct key proteins of short half-life.
Rapid and virtually complete (ϳ95% after 1 h) blockade of protein synthesis was achieved by 10 m CHX, an inhibitor of translation. The sensitivity of our preparation of mouse islets to CHX was similar to that of rat islets in which 1-10 m CHX inhibited protein synthesis by 75-95% (37-39). The present results confirm the observations (16 -19) that the inhibition of insulin secretion by CHX starts only after about 1 h of drug application. They further show that there is a time lag between the reversibility of the inhibition of protein synthesis and insulin secretion. Thus, both onset and offset of the inhibition of secretion are delayed compared with those of protein synthesis. Several observations also indicate that the changes in ␤ cell function produced by CHX are not secondary to a crude toxic effect: their reversibility, the minor alteration of glucose metabolism even after 20 h, and the longer delay (2-3 days) before appearance of apoptosis in CHX-treated ␤ cells (40) . It seems reasonable to propose that the time-dependent changes in stimulus-secretion coupling produced by addition and removal of CHX result from disappearance and reappearance of proteins with distinct half-lives.
The inhibition of insulin secretion measured after 2 h of CHX treatment cannot be explained by insufficient total insulin stores, but could theoretically result from the depletion of a finite, small pool of insulin that cannot be replenished because of the suppression of insulin biosynthesis. Newly synthesized insulin can be released rapidly without the newly formed granules mixing with the older ones (20, 21, 41, 42) . However, this only corresponds to a small (Ͻ10%) fraction of total insulin secretion (20, 21, 43) , much smaller than the approximately 50% inhibition observed here already after 2 h. After longer treatment of the islets with CHX (18 h) insulin reserves were higher than in untreated controls. We, therefore, conclude that neither the initial nor the sustained effect of CHX on insulin secretion is mediated by the loss of a particular pool of insulin.
Insulin secretion is tightly dependent on glucose metabolism in ␤ cells. A slight (ϳ15%) decrease in glucose-induced rise in NAD(P)H fluorescence and in glucose oxidation was observed after 20 h of protein synthesis inhibition. This inhibition of glucose metabolism may contribute to the delayed inhibition of insulin secretion, but it is too small to explain it entirely. In contrast, we did not observe any impairment of the NAD(P)H signal after 5 h of CHX treatment, and others have reported that glycolysis and glucose oxidation in mouse islets are unaffected by 1 mm CHX after 2-3 h (44, 45) . The inhibition of insulin secretion occurring during the first hours of protein synthesis inhibition cannot be ascribed to any major defect in glucose metabolism. It can also be concluded that the proteins involved in glucose metabolism have a relatively long half-life, which may explain why ␤ cells can survive a few days without protein synthesis (40) . K ϩ -ATP channels serve as transduction units between nutrient metabolism and biophysical events in ␤ cells, and are the direct target of sulfonylureas (4 -6, 15 ). An inhibition of insulin secretion could result from an impairment of the ability of glucose or tolbutamide to close the channels. Neither 86 Rb ϩ efflux measurements nor patch-clamp recordings suggested that this might be the case after 5 or 20 h of protein synthesis inhibition. The maximum K ϩ -ATP current activated by metabolic poisoning and diazoxide was decreased by approximately 50% in ␤ cells treated with CHX for 20 h. Because over 90% K ϩ -ATP channels must be closed before the ␤ cell membrane depolarizes (46, 47) , a 50% decrease in available channels is not expected to cause major effects on ␤ cell function. It may explain, why basal 86 Rb ϩ efflux was slightly decreased in test islets, but it is important to note that this decrease was less than that produced in control islets by 3 mm glucose, a concentration that is insufficient to depolarize ␤ cells (36) .
Upon (3) (4) (5) (6) 27) . Not only glucose and tolbutamide, but also high K ϩ , that depolarizes independently of K ϩ -ATP channels (by shifting the equilibrium potential for K ϩ ), were less effective in increasing [Ca 2ϩ ] i after 20 h of protein synthesis inhibition. This reduced efficacy is entirely compatible with the commensurate decrease in Ca 2ϩ current measured in similarly treated ␤ cells. Whether the actual number of Ca 2ϩ channels is decreased by 40% under these conditions or whether the availability of the channels is reduced because of the loss of a regulatory protein cannot be answered by these experiments. Two other aspects of the specific [Ca 2ϩ ] i response to glucose were perturbed after 20 h of CHX treatment: the small decrease preceding the initial rise, and the oscillations occurring during sustained stimulation were abrogated. The significance of these changes is difficult to establish because the inhibition of glucose-induced insulin se- cretion after 5 h of CHX was accompanied by an absence of the initial [Ca 2ϩ ] i decrease in 70% of the islets but a persistence of [Ca 2ϩ ] i oscillations in all islets. Anyhow it is intriguing that the small initial decrease, which reflects glucoseinduced Ca 2ϩ sequestration in the endoplasmic reticulum (48) , is lost in ␤ cells from diabetic db/db mice (49) . From our data, one may conclude that a lesser rise in ␤ cell [Ca 2ϩ ] i , secondary to a decrease in functional Ca 2ϩ channels, contributes to the inhibition of insulin secretion probably after 5 and certainly after 20 h of protein synthesis inhibition. However, no similar mechanism explains the inhibition of insulin secretion after 2 h.
A major observation of the present study was that short (2 h) treatment of the islets with CHX inhibited insulin secretion without impairing the rise in [Ca 2ϩ ] i produced by three distinct agents, glucose, tolbutamide and high K ϩ . This dissociation indicates that the efficacy of Ca 2ϩ on secretion was decreased. Thus, the relationship between [Ca 2ϩ ] i and insulin secretion in response to the three agents could be fitted by distinct, tight correlations corresponding to the absence and presence of CHX, respectively. Moreover, after resumption of protein synthesis (after CHX washing), the recovery of insulin secretion was more dependent on restoration of the action of Ca 2ϩ than elevation of [Ca 2ϩ ] i . Altogether our data indicate that protein synthesis inhibition in ␤ cells inhibits insulin secretion in sequential steps: a decrease in the efficiency of Ca 2ϩ , followed by a decrease in Ca 2ϩ influx and glucose metabolism.
The synthesis of a distinct subset of islet proteins other than proinsulin is stimulated by glucose (50 -52) . Among these proteins, other secretory peptides and proteolytic enzymes involved in prohormone processing have been identified. Many others are unknown and might include proteins whose loss rapidly leads to impairment of insulin secretion. We have not identified these proteins that seem to be distinct from protein kinases A and C and their targets because activation of these kinases normally potentiated insulin secretion after short treatment with CHX. We speculate that these proteins might be implicated in the amplification pathway of glucose-induced insulin secretion (1, (7) (8) (9) , the pathway through which glucose increases the efficiency of Ca 2ϩ on exocytosis of insulin granules. It is, however, not necessary to postulate that these proteins with a short half-life are glucose dependent. They could also be important in other secretory systems.
In conclusion, islet protein inhibition impairs insulin secretion by a sequential alteration of distinct steps of stimulussecretion coupling. Glucose metabolism is not readily affected, which indicates that the involved enzymes have a relatively long half-life. K ϩ -ATP and Ca 2ϩ channels may be similarly affected but only the decrease in Ca 2ϩ channels exerts a negative impact on insulin secretion. Unexpectedly, among all ␤ cell proteins implicated in the regulation of insulin secretion, that or those with the shortest half-life appear to modulate (directly or indirectly) the action of Ca 2ϩ on exocytosis. These characteristics make them the potential Achille's heel of stimulus-secretion coupling in ␤ cells. 
